Search – Page 78 – Indianapolis Business Journal

Home » Search

Articles

Assessing Elanco options: sale, spinoff or status quo?

November 2, 2017

Lilly CEO David Ricks says the time is right “to consider a variety of options to maximize future value,” such as an initial public offering. But analysts say an IPO would make more sense if Elanco were performing better.

Tobias gift of $5M to establish IU global development center

October 31, 2017

Indiana University will create a research laboratory focused on international development—including missions such as reducing poverty and inequality and addressing climate change—based on a $5 million gift from Deborah and Randall Tobias.

2017 WOMAN OF INFLUENCE: Yolanda Johnson-Moton

October 27, 2017

Since joining Eli Lilly and Co., Yolanda Johnson-Moton has launched education and engagement platforms, including the Lilly for Better Health website, and brought the company to YouTube via Lilly Health Channel.

2017 WOMAN OF INFLUENCE: Joyce Irwin

October 27, 2017

Joyce Irwin directs the Community Health Network Foundation, which is dedicated to serving the needs of both patients and caregivers with funding for programs such as an Oncology Assistance Fund.

2017 WOMAN OF INFLUENCE: Melissa Stapleton Barnes

October 27, 2017

At Eli Lilly and Co., Melissa Stapleton Barnes leads an organization responsible for ethics and compliance in nearly 90 countries around the world.

Lilly shares slide on news of possible sale, spinoff of Elanco

October 24, 2017

Despite slipping sales and lost market share, the Elanco animal-health unit is strong and the time is right to explore selling or spinning it off, Eli Lilly and Co. officials said Tuesday.

Lilly considers sale, spinoff of Elanco animal-health business

October 24, 2017

The company announced Tuesday that it is reviewing options for the Greenfield-based division, "including an initial public offering, merger, sale, or retention of the business."

Lilly takes big bet on German startup’s cancer technology

October 23, 2017

The Indianapolis-based drugmaker is collaborating with CureVac AG to develop up to five cancer products. The products will be based on a new field of biotechnology sweeping the industry.

Lilly plans $72M upgrade for Indianapolis insulin operation

October 23, 2017

The Indianapolis drugmaker said it will use the money to replace an existing line that fills vials for Humalog and Humulin and to prepare for new insulin products.

Holcomb taking global approach to economic development

October 21, 2017

The governor helped persuade India-based outsourcing firm Infosys to establish offices in Indianapolis, got skeptical GOP lawmakers to fund a direct flight between Indianapolis and Paris, and signed an agreement to deepen economic ties with Japan.

Guaranty Building magnet for tech firms

October 19, 2017

Salesforce has left for its namesake tower across the Circle as part of a big downtown expansion, but the nearly emptied Guaranty is making a quick comeback and attracting prized tenants.

Trump considers former Lilly exec for HHS post

October 18, 2017

Before joining Eli Lilly and Co., Alex Azar served as the general counsel and deputy secretary of Health and Human Services Administration under President George Bush.

Athlete group launches platform for investing in minority businesses

October 11, 2017

Former Pacers star Antonio Davis is among the leaders of Playbook Investors Network, which helps support and provide access to capital for minority-owned supplier firms.

Athlete group launches platform for investing in minority businesses

October 11, 2017

Former Pacers big man Antonio Davis is among a cohort of athletes behind an investing platform that targets investments in minority-owned supplier companies.

Zionsville pharmacist who put himself in feds’ sights admits to felonies

October 6, 2017

Harry Zhang pleaded guilty to two felonies this month after charged with illegally obtaining prescriptions from Canada and Germany and reselling them in China.

City hush-hush about Amazon HQ2 bid

October 5, 2017

Central Indiana is facing crunch time in its push to bid for the Amazon HQ2 project, with pitches to the Seattle-based company due Oct. 19, less than two weeks away.

Brinegar: Tax plan would drive investments, income growth

October 4, 2017

Encouraging business investment and accelerating economic growth are always winning strategies. Additional elements of the administration’s proposal bring more benefits for all Hoosier taxpayers.

FDA acts to encourage generic competition for complex drugs

October 3, 2017

The U.S. Food and Drug Administration is opening a new front in its efforts to reduce high drug prices by encouraging development of generic versions of hard-to-make medicines.

Another insulin biotech pops up in Indy with plans for new lab

October 2, 2017

Thermalin Inc., a Cleveland-based biotech startup that just won $17.5 million in venture capital to develop new insulin therapies, plans to add several researchers to a lab at the Indiana University School of Medicine.

Lilly names new CFO, head of R&D

September 29, 2017

The appointments mark the latest changes in the Indianapolis-based drugmaker’s executive suite since David Ricks took over as CEO in January.

« Previous 1 … 76 77 78 79 80 … 221 Next »

Search Results

4,410 results for '\"eli lilly\"'

Articles

Assessing Elanco options: sale, spinoff or status quo?

Tobias gift of $5M to establish IU global development center

2017 WOMAN OF INFLUENCE: Yolanda Johnson-Moton

2017 WOMAN OF INFLUENCE: Joyce Irwin

2017 WOMAN OF INFLUENCE: Melissa Stapleton Barnes

Lilly considers sale, spinoff of Elanco animal-health business

Lilly takes big bet on German startup’s cancer technology

Lilly plans $72M upgrade for Indianapolis insulin operation

Holcomb taking global approach to economic development

Guaranty Building magnet for tech firms

Trump considers former Lilly exec for HHS post

Athlete group launches platform for investing in minority businesses

Athlete group launches platform for investing in minority businesses

Zionsville pharmacist who put himself in feds’ sights admits to felonies

City hush-hush about Amazon HQ2 bid

Brinegar: Tax plan would drive investments, income growth

FDA acts to encourage generic competition for complex drugs

Another insulin biotech pops up in Indy with plans for new lab

Lilly names new CFO, head of R&D